한국어
Home › US companies › Icon

Icon

ICLR · Nasdaq · Services-Commercial Physical & Biological Research
Insider buys (12 months)
0
Insider sales (12 months)
$3.5M
8-K reports (12 months)
0
Tracked investors holding
0

At a glance

Icon reported 2025 revenue of $8.25B, up 0.8% from $8.19B in 2024. Over 4 years since 2021 ($5.48B), that is growth of about 10.8% a year. Operating margin was 5.4%, down from 6.9% in 2021. 2025 was the highest revenue year in this period.

In the last 12 months 8 insiders reported 0 open-market purchases and 9 sales ($3.5M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $876K by Director Ronan Martin Murphy on Sep 18, 2026.

Annual results

2021
Revenue $5.48B
Op. $378.5M
2022
Revenue $7.74B
Op. $795.2M
2023
Revenue $8.05B
Op. $904.7M
2024
Revenue $8.19B
Op. $1.03B
2025
Revenue $8.25B
Op. $442.8M
RevenueOperating income (or net income)SEC XBRL annual filings, fiscal years mapped to calendar years
Year20212022202320242025
Net income$153.2M$505.3M$554.2M$739.1M$229.3M
Diluted EPS$2.25$6.13$6.70$8.90$2.90

Insider open-market trades (last 12 months)

10/26SaleChief Accounting Officer Emer Lyons sold 272 sh at $182.37, Oct 23.$50K
9/18SaleDirector Ronan Martin Murphy sold 5,005 sh at $175.00, Sep 17.$876K
9/18SaleDirector John Dr Climax sold 5,005 sh at $175.00, Sep 16.$876K
9/18SaleDirector Eugene Pacelli Mccague sold 3,255 sh at $175.00, Sep 17.$570K
8/12SaleDirector Ciaran Murray sold 2,677 sh at $164.29, Aug 11.$440K
8/12SaleChief Financial Officer Nigel Bernard John Clerkin sold 2,267 sh at $164.29, Aug 11.$372K
8/12SaleDirector Julie O'Neill sold 915 sh at $164.29, Aug 11.$150K
8/12SaleDirector John Dr Climax sold 841 sh at $164.29, Aug 11.$138K
8/11SaleChief Executive Officer Barry Edward Balfe sold 382 sh at $164.07, Aug 10.$63K

Source: SEC EDGAR. How figures are combined